Making experimental drugs available for AIDS treatment.
D000163:Acquired Immunodeficiency Syndrome; D004345:Drug Industry; D064420:Drug-Related Side Effects and Adverse Reactions; D004467:Economics; D035082:Federal Government; D005610:Freedom; D006076:Government; D033161:Government Regulation; D006805:Human Experimentation; D006801:Humans; D009369:Neoplasms; D005791:Patient Care; D010361:Patients; D026684:Personal Autonomy; D004364:Pharmaceutical Preparations; D010820:Physicians; D011640:Public Policy; D012106:Research; D012306:Risk; D018570:Risk Assessment; D012926:Social Control, Formal; D019452:Terminally Ill; D036302:Therapeutic Human Experimentation; D014481:United States; D014486:United States Food and Drug Administration
Health Care and Public Health